AF Reversal Programme

Atrial fibrillation doesn’t have to mean a lifetime of escalating treatment.

A personalised, research-backed programme that addresses the root causes of AF — not just the rhythm.

The Current Pathway

All AF is not the same. Current pathways treat it as if it were.

AF has many causes. Yet in modern healthcare, it is largely treated the same way regardless. Protocols and pathways are, by design, one-size-fits-all — and in the UK particularly, they are increasingly medical and procedural in their default direction.

Because the pathway is automated rather than personalised, it is more likely to fail at each stage — and failure triggers escalation to the next step. Patients presenting with AF for the first time are frequently offered cardioversion. Without the right preparation, the long-term success rate can be poor. With the right preparation, outcomes change dramatically. But when cardioversion fails, the pathway moves quickly to catheter ablation — often without pausing to ask whether the underlying conditions driving the AF have been addressed at all.

There is a broader dynamic worth acknowledging. Procedural cardiologists are trained to intervene — and are naturally enthusiastic about the procedures they have mastered. The influence of device and pharmaceutical companies on clinical evidence and guidance is real, if rarely discussed openly. None of this is unique to cardiology. But it is worth being aware of when navigating your options.

Metabolic AF

The patients most likely to benefit — and why.

When AF occurs in younger patients — typically in their forties and fifties — lifestyle factors are frequently the underlying driver. This is increasingly recognised as a distinct clinical entity: metabolic AF.

The patients where this approach is most effective are those with underlying metabolic health problems. These frequently present alongside other conditions: type 2 diabetes, gout, obstructive sleep apnoea, high blood pressure, and high cholesterol. In modern healthcare, each of these is typically medicalised individually — a separate drug for each separate condition. By addressing the underlying root cause, we see universal improvement across all of them, including — in many patients — reversal of the atrial fibrillation itself.

The Evidence

Underpinned by research. Anchored in clinical practice.

The landmark REVERSE-AF study demonstrated that atrial fibrillation can be reversed — moving from persistent AF back to paroxysmal, and from paroxysmal back to no detectable AF — through targeted lifestyle intervention. This is not a fringe hypothesis. It is peer-reviewed, published evidence.

Our own programme has developed through active research with the University of Bath, and this work continues. Both in clinical practice and in research, we have demonstrated that many patients heading towards catheter ablation can avoid invasive treatment through earlier, targeted lifestyle intervention. In those who do proceed to cardioversion or ablation, the preparation we put in place substantially improves the likelihood of success.

Our Approach

Four steps. One continuous, personalised pathway.

Comprehensive clinical assessment

A thorough evaluation of the atrial fibrillation in the specific context of that patient. Not a generic AF workup — a genuinely personalised assessment of what is driving the rhythm disturbance in this individual, and what that means for their pathway.

Advanced cardiovascular diagnostics

Investigations that look beyond the electrics alone. AF rarely exists in isolation. A comprehensive assessment of the whole cardiovascular system informs a more accurate picture of risk, cause, and opportunity for intervention.

Personalised medical strategy

An unbiased overview of the most appropriate medical approach — focused on immediate symptom control and rhythm improvement, without defaulting automatically to procedural escalation. Anti-arrhythmic therapy, where appropriate, is used deliberately and early to stabilise the rhythm and create the conditions for lifestyle intervention to work.

Targeted lifestyle programme

Where metabolic factors are present, a specific dietary and exercise programme with a direct evidence base for AF reversal. This is not generic lifestyle advice. It is a targeted clinical intervention, informed by our research and the emerging evidence base in this area, delivered in conjunction with our CardioFIT programme where appropriate.

A Note on Procedures

Procedures are not wrong. They work better when you are properly prepared.

Cardioversion and catheter ablation are not wrong. They are frequently the right answer. But they work significantly better when the patient has been properly prepared and the underlying drivers of the arrhythmia have been addressed. Our programme does not reject procedural treatment — it ensures that when it is needed, it succeeds.

Who Should Consider This Programme

This programme is most effective in the right patients.

This programme is most effective in patients with metabolic AF — those with type 2 diabetes, gout, obstructive sleep apnoea, hypertension, or high cholesterol as accompanying conditions. The evidence base for lifestyle reversal is strongest in this group, and the potential gains are greatest.

Beyond metabolic AF, this programme is well suited to patients who find themselves on a standard pathway that feels automated rather than personalised; patients who are heading towards or awaiting cardioversion or catheter ablation and want to optimise their preparation; patients who have had procedures that have not held and want to address root causes before repeating; and patients who want to understand the full picture before committing to an invasive approach.

Atrial fibrillation becomes increasingly prevalent with age, affecting more than one in ten people over eighty. The question for every patient is not simply which procedure to choose — it is whether the conditions that created and sustain the AF have been properly addressed. That is what this programme does.

Related programmes

Screening & Prevention

The technology to predict your cardiovascular future exists.

Explore the programme →

Cholesterol & Lipid Management

High cholesterol doesn’t automatically mean you need a statin.

Explore the pathway →

The tools to address atrial fibrillation at its root cause exist. The question is whether they are used thoughtfully — or simply reached for automatically.

Arrange a consultation

Speak with Tash — 01761 422287